EL SEGUNDO, Calif. — Gov. Gavin Newsom announced Thursday that CalRx biosimilar insulin glargine pens will be available to consumers in California beginning Jan. 1, 2026. The launch comes amid the ...

California has launched a program to manufacture and sell lower-cost insulin to people with diabetes. State officials say consumers will be able to purchase a five-pack of insulin pens for $55 in ...

MONDAY, Oct. 20, 2025 (HealthDay News) — California will start selling low-cost insulin Jan. 1, nearly three years after Gov. Gavin Newsom announced a plan to make lifesaving medications more ...

Javascript is required for you to be able to read premium content. Please enable it in your browser settings.

Gov. Gavin Newsom speaks during a news conference announcing $11 insulin and prescription drugs with the CalRx program inside a Cedars-Sinai pharmacy in Los Angeles on Thursday. The effort is part of ...

Californians will be able to buy five packs of insulin pens for a maximum of $55 per pack, or $11 per pen, starting Jan. 1. The insulin is from a state-branded form of the medicine, CalRx. Lawmakers ...

Civica announced today that it plans to launch an affordable long-acting insulin in pre-filled pens starting in January 2026. The company plans to launch insulin glargine-yfgn in pre-filled pens at ...

Non inferior HbA1c reduction at 26 weeks (primary endpoint) Significant reduction of the rise of blood glucose after a test meal (key secondary endpoint) Blood glucose level, monitored by 10-point ...

Diabetes management has come a long way, and the tools we use are getting smarter. For a long time, it felt like insulin pumps were the only real game in town for high-tech diabetes care. But what ...